MLchartDataset catalogue

Stivarga

Term · Oncology and biomedicine · MLC-T-ONC-008322

A drug used to treat certain types of colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma (a type of liver cancer). It is also being studied in the treatment of other types of cancer. Stivarga blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Stivarga is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called regorafenib.

Table 1. Record
IdentifierMLC-T-ONC-008322
FieldOncology and biomedicine
Synonymsregorafenib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008322",
  "term": "Stivarga",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat certain types of colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma (a type of liver cancer). It is also being studied in the treatment of other types of cancer. Stivarga blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Stivarga is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called regorafenib.",
  "synonyms": [
    "regorafenib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/stivarga/"
}

Record 15,703 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.